https://www.selleckchem.com/pr....oducts/gliocidin.htm
90 and 0.87, respectively. Items of NPSI were placed in 4 factors. A moderate to the strong association (r = 0.55 to 0.85) between NPSI and other scales was obtained. The results of discriminative validity and sensitivity to change indicate the ability of NPSI to show differences between medication states. The results of this study suggest that NPSI has acceptable reliability, validity, and sensitivity to change, indicating that this scale is suitable for measuring neuropathic pain in Iranian people with Parkinson's disease. The resu
お気に入り
コメント
シェア
